To include your compound in the COVID-19 Resource Center, submit it here.

Consortium including Gao, GL Capital bid to take China Biologic private

A consortium comprising former executive David Gao, GL Capital Group, Bank of China Group Investment Ltd. and CDH Investments proposed

Read the full 204 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE